Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02107105 · ClinicalTrials.gov registry record

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
430
Enrollment target

NCT02107105: Recruiting study, sponsored by M.D. Anderson Cancer Center.

NCT02107105 is a clinical trial that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 430 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02107105 is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
430 participants
Enrollment target

Study Summary

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2014-05-16
Est. Completion 2030-05-31

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02107105

The ClinicalTrials.gov registry entry for NCT02107105 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.

NCT02107105 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02107105 about?

NCT02107105 is a clinical study titled "Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer". This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

What is the current status of trial NCT02107105?

This trial is currently recruiting. The enrollment target is 430 participants. The study started on 2014-05-16. Estimated completion is 2030-05-31.

What interventions are being tested in trial NCT02107105?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT02107105?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.